Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05711485 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Platelet-Directed Whole Blood Transfusion Strategy for Malaria

Study acronym: PLATFORM
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Eligibility criteria revised
    • Study description revised
    • Study sites revised (2)
    v7
  2. Primary completion date: Apr 30, 2026 to Apr 30, 2027
    • Study completion date: Apr 30, 2027 to May 31, 2028
    v6
  3. Primary completion date: Nov 30, 2024 to Apr 30, 2026
    • Study completion date: Feb 28, 2025 to Apr 30, 2027
    v5
  4. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Mar 1, 2024 to Feb 24, 2024
    • Site details revised at 2 of 2 sites
    v4
  5. Start date: Nov 1, 2023 to Mar 1, 2024
    • Primary completion date: Jul 31, 2024 to Nov 30, 2024
    • Study completion date: Jul 31, 2024 to Feb 28, 2025
    v3
  6. Start date: Aug 1, 2023 to Nov 1, 2023v2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Open-label randomized controlled trial to test the effectiveness of whole blood transfusion for improving survival in children with severe malaria complicated by thrombocytopenia.
Trial Details
NCT Number NCT05711485
Lead Sponsor Johns Hopkins Bloomberg School of Public Health
Collaborators: Johns Hopkins University, Tropical Diseases Research Centre, University of California, San Francisco, University of Maryland
Conditions
(from sponsor)		 Severe Malaria, Thrombocytopenia
Related terms Malaria, Malaria, Falciparum, Thrombocytopenia
Enrollment 132 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov